PHEMI Closes $12.2 Million Venture Financing
August 11, 2015
VANCOUVER, BC – PHEMI, the company delivering security, privacy, and governance insights through the promise of big data, today announced it has raised a $12.2 million round of venture financing to expand the commercialization phase of the company. Secured by a combination of new and existing investors, the financing was co-led by CTI Life Sciences Fund (CTI) and British Columbia Discovery Fund (Discovery Capital) and included significant participation from early investors BDC Capital Healthcare Venture Fund and Yaletown Venture Partners.
A team of serial entrepreneurs, Dr. Paul Terry, Adam Lorant and John Seminerio—with expertise in developing and commercializing innovative business and technology solutions for a wide variety of industries, including healthcare, telecommunications, and high-performance computing—joined Chris Thompson and Alan Rabinowitz, two St. Paul’s Hospital cardiologists, in their start-up called PHEMI. With its initial focus in the healthcare and life sciences sectors, PHEMI will expand its focus to include a variety of data-driven communities, including public sector, insurance, and financial services.
In the news
Yaletown Partners was proud to work closely with one of our Portfolio Companies, GoBolt, in their recent announcement of raising m…
December 7, 2022
Yaletown Partners is thrilled to be featured in the 2022 edition of The 50: A Guide to the Canadian Venture Capital Ecosystem, a c…
November 17, 2022